Nebula Research & Development’s CARGO Therapeutics CRGX Stock Holding History

Nebula Research & Development’s Portfolio CRGX Stock Details CRGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10,526	Closed	-$43.4K	–	210
2025 Q2	$43.4K	Sell	10,526 -3,608	-26%	-$15.5K	﹤0.01%	935
2025 Q1	$57.5K	Buy	+14,134	New	+$94.7K	0.01%	918

Other funds holding CRGX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Nebula Research & Development's CRGX Position: Q3 2025 in Review

Nebula Research & Development sold out of CARGO Therapeutics (CRGX) in Q3 2025, closing a stake of 10,526 shares — an estimated $43.4K sold.

Nebula Research & Development first reported a position in CRGX in Q1 2025 and held it in 2 quarters. The position peaked at $57.5K in Q1 2025. 1 fund tracked by Wall St. Rank holds CRGX as of Q3 2025.

Nebula Research & Development reported no remaining CARGO Therapeutics position as of Q3 2025 after selling out during the quarter.
Nebula Research & Development sold 10,526 CARGO Therapeutics shares in Q3 2025, an estimated $43.4K.
Nebula Research & Development first reported a position in CARGO Therapeutics in Q1 2025 and held it in 2 quarters.
Nebula Research & Development's CARGO Therapeutics position peaked at $57.5K in Q1 2025.
1 fund tracked by Wall St. Rank held CARGO Therapeutics as of Q3 2025.

Based on Nebula Research & Development's 13F filing for Q3 2025.